HY:NYSEHyster-Yale, Inc. Analysis

Hyster-Yale (HY) trades at $35.19, just below its 50‑day SMA of $34.67 but beneath the 200‑day SMA of $35.52, indicating a lingering bearish bias despite a bullish MACD histogram (+0.43) and a moderate RSI of 58.4. The stock sits on a support level near $29.01 with resistance at $35.45, while volume has been decreasing and 30‑day volatility is high at 61.6%, reflecting a choppy market environment and a beta of 1.46 that amplifies sector moves. Fundamentally, the company posted a 13.5% revenue decline to $3.77 bn, negative operating margins (‑1.8%) and a trailing EPS of –$3.40, yet forward EPS is projected at $0.97 and bookings surged 42% sequentially, hinting at a potential demand rebound.
Valuation metrics are concerning: a DCF fair value of $16.50 suggests the market price is roughly 33% overvalued, the forward P/E of 36.3 exceeds the industry average of 30.7, and the debt‑to‑equity ratio of 130% raises leverage risk. Nonetheless, the dividend yield of 4.09% with a modest 10% payout ratio, positive operating cash flow of $86.1 m, and a stable PB of 1.32 provide a cushion for income‑focused investors while the company navigates tariff challenges and aims to convert higher bookings into earnings.